Glaukos (GKOS) Share-based Compensation (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.66% |
| Dec 31, 2025 | 16.01% |
| Sep 30, 2025 | -17.24% |
| Jun 30, 2025 | 38.76% |
| Mar 31, 2025 | -2.43% |
| Dec 31, 2024 | -7.70% |
| Sep 30, 2024 | 27.46% |
| Jun 30, 2024 | 1.33% |
| Mar 31, 2024 | -14.03% |
| Dec 31, 2023 | 23.87% |
| Sep 30, 2023 | 6.19% |
| Jun 30, 2023 | -3.05% |
| Mar 31, 2023 | -12.87% |
| Dec 31, 2022 | 24.20% |
| Sep 30, 2022 | -10.70% |
| Jun 30, 2022 | 52.23% |
| Mar 31, 2022 | -4.18% |
| Dec 31, 2021 | 16.74% |
| Sep 30, 2021 | -22.48% |
| Jun 30, 2021 | -8.73% |
| Mar 31, 2021 | -26.59% |
| Dec 31, 2020 | 23.37% |
| Sep 30, 2020 | -11.36% |
| Jun 30, 2020 | -22.19% |
| Mar 31, 2020 | -9.98% |
| Dec 31, 2019 | 82.03% |
| Sep 30, 2019 | 3.64% |
| Jun 30, 2019 | 15.68% |
| Mar 31, 2019 | 6.91% |
| Dec 31, 2018 | -7.04% |
| Sep 30, 2018 | 11.02% |
| Jun 30, 2018 | 19.60% |
| Mar 31, 2018 | 9.37% |
| Dec 31, 2017 | 4.71% |
| Sep 30, 2017 | -0.36% |
| Jun 30, 2017 | 47.85% |
| Mar 31, 2017 | 19.97% |
| Dec 31, 2016 | 0.68% |
| Sep 30, 2016 | 29.44% |
| Jun 30, 2016 | 44.53% |
| Mar 31, 2016 | -9.05% |
| Dec 31, 2015 | 0.39% |
| Sep 30, 2015 | -64.78% |
| Jun 30, 2015 | 1,148.16% |
| Mar 31, 2015 | -11.75% |
| Dec 31, 2014 | 2.04% |
| Sep 30, 2014 | 7.69% |